The aim of this study was to evaluate if U-NGAL can be used as a diagnostic marker to identity very preterm neonates with a PDA causing hemodynamic changes resulting in renal morbidity within the first week of life. The gene discussed is LCN2; the disease is Patent ductus arteriosus.